Birmingham Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12M | Sell |
9,985
-445
| -4% | -$455K | 4.55% | 3 |
|
|
2026
Q1 | $9.59M | Sell |
10,430
-1,500
| -13% | -$1.52M | 4.05% | 4 |
|
|
2025
Q4 | $12.8M | Hold |
11,930
| – | – | 5.65% | 3 |
|
|
2025
Q3 | $9.1M | Buy |
11,930
+1,600
| +15% | +$1.19M | 4.18% | 5 |
|
|
2025
Q2 | $8.05M | Sell |
10,330
-795
| -7% | -$618K | 3.56% | 5 |
|
|
2025
Q1 | $9.19M | Sell |
11,125
-275
| -2% | -$229K | 3.46% | 5 |
|
|
2024
Q4 | $8.8M | Sell |
11,400
-1,475
| -11% | -$1.22M | 3.26% | 5 |
|
|
2024
Q3 | $11.4M | Sell |
12,875
-1,025
| -7% | -$922K | 4.15% | 3 |
|
|
2024
Q2 | $12.6M | Sell |
13,900
-2,005
| -13% | -$1.6M | 4.91% | 3 |
|
|
2024
Q1 | $12.4M | Sell |
15,905
-25
| -0.2% | -$17.8K | 4.55% | 3 |
|
|
2023
Q4 | $9.29M | Sell |
15,930
-590
| -4% | -$344K | 3.67% | 4 |
|
|
2023
Q3 | $8.87M | Buy |
16,520
+140
| +0.9% | +$72.1K | 3.67% | 5 |
|
|
2023
Q2 | $7.68M | Sell |
16,380
-410
| -2% | -$172K | 3.22% | 7 |
|
|
2023
Q1 | $5.77M | Buy |
16,790
+100
| +0.6% | +$33.7K | 2.3% | 14 |
|
|
2022
Q4 | $6.11M | Sell |
16,690
-85
| -0.5% | -$30.1K | 2.32% | 13 |
|
|
2022
Q3 | $5.42M | Sell |
16,775
-3,425
| -17% | -$1.09M | 2.4% | 12 |
|
|
2022
Q2 | $6.55M | Sell |
20,200
-1,650
| -8% | -$495K | 2.61% | 11 |
|
|
2022
Q1 | $6.26M | Hold |
21,850
| – | – | 2.18% | 15 |
|
|
2021
Q4 | $6.04M | Hold |
21,850
| – | – | 2.18% | 14 |
|
|
2021
Q3 | $5.05M | Hold |
21,850
| – | – | 1.93% | 16 |
|
|
2021
Q2 | $5.01M | Sell |
21,850
-25
| -0.1% | -$5.02K | 1.84% | 17 |
|
|
2021
Q1 | $4.09M | Sell |
21,875
-100
| -0.5% | -$19.6K | 1.53% | 21 |
|
|
2020
Q4 | $3.71M | Hold |
21,975
| – | – | 1.53% | 22 |
|
|
2020
Q3 | $3.25M | Hold |
21,975
| – | – | 1.48% | 22 |
|
|
2020
Q2 | $3.61M | Hold |
21,975
| – | – | 1.76% | 19 |
|
|
2020
Q1 | $3.05M | Sell |
21,975
-840
| -4% | -$115K | 1.68% | 22 |
|
|
2019
Q4 | $3M | Sell |
22,815
-300
| -1% | -$34.8K | 1.33% | 26 |
|
|
2019
Q3 | $2.58M | Sell |
23,115
-2,500
| -10% | -$278K | 1.19% | 28 |
|
|
2019
Q2 | $2.84M | Hold |
25,615
| – | – | 1.28% | 27 |
|
|
2019
Q1 | $3.32M | Sell |
25,615
-250
| -1% | -$30.4K | 1.49% | 24 |
|
|
2018
Q4 | $2.99M | Sell |
25,865
-400
| -2% | -$44.7K | 1.46% | 24 |
|
|
2018
Q3 | $2.82M | Hold |
26,265
| – | – | 1.16% | 33 |
|
|
2018
Q2 | $2.24M | Hold |
26,265
| – | – | 0.96% | 38 |
|
|
2018
Q1 | $2.03M | Sell |
26,265
-2,250
| -8% | -$181K | 0.84% | 42 |
|
|
2017
Q4 | $2.41M | Sell |
28,515
-225
| -0.8% | -$19.1K | 0.92% | 40 |
|
|
2017
Q3 | $2.46M | Hold |
28,740
| – | – | 0.98% | 37 |
|
|
2017
Q2 | $2.37M | Hold |
28,740
| – | – | 0.95% | 39 |
|
|
2017
Q1 | $2.42M | Hold |
28,740
| – | – | 0.98% | 40 |
|
|
2016
Q4 | $2.11M | Hold |
28,740
| – | – | 0.89% | 41 |
|
|
2016
Q3 | $2.26M | Hold |
28,740
| – | – | 1% | 39 |
|
|
2016
Q2 | $2.26M | Hold |
28,740
| – | – | 0.99% | 39 |
|
|
2016
Q1 | $2.07M | Sell |
28,740
-1,350
| -4% | -$102K | 0.84% | 41 |
|
|
2015
Q4 | $2.54M | Sell |
30,090
-250
| -0.8% | -$20.7K | 1.03% | 38 |
|
|
2015
Q3 | $2.54M | Sell |
30,340
-550
| -2% | -$46.4K | 1.11% | 37 |
|
|
2015
Q2 | $2.58M | Sell |
30,890
-1,750
| -5% | -$133K | 1.01% | 39 |
|
|
2015
Q1 | $2.37M | Buy |
32,640
+5,750
| +21% | +$409K | 0.9% | 40 |
|
|
2014
Q4 | $1.85M | Sell |
26,890
-6,115
| -19% | -$413K | 0.71% | 47 |
|
|
2014
Q3 | $2.14M | Sell |
33,005
-100
| -0.3% | -$6.33K | 0.81% | 44 |
|
|
2014
Q2 | $2.06M | Hold |
33,105
| – | – | 0.75% | 46 |
|
|
2014
Q1 | $1.95M | Buy |
33,105
+250
| +0.8% | +$14K | 0.74% | 46 |
|
|
2013
Q4 | $1.68M | Hold |
32,855
| – | – | 0.63% | 48 |
|
|
2013
Q3 | $1.65M | Buy |
32,855
+3,235
| +11% | +$169K | 0.66% | 49 |
|
|
2013
Q2 | $1.46M | Buy |
+29,620
| New | +$1.61M | 0.6% | 54 |
|
Other funds holding LLY
Birmingham Capital Management's LLY Position: Q2 2026 in Review
Birmingham Capital Management reduced its Eli Lilly (LLY) stake by 4.3% in Q2 2026, selling an estimated $455K and leaving 9,985 shares worth $12M. The position accounts for 4.55% of the portfolio, ranked #3.
Birmingham Capital Management first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $12.8M in Q4 2025. 4,597 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Birmingham Capital Management held 9,985 shares of Eli Lilly worth $12M as of Q2 2026.
- Birmingham Capital Management sold 445 Eli Lilly shares in Q2 2026, an estimated $455K.
- Eli Lilly made up 4.55% of Birmingham Capital Management's portfolio in Q2 2026, its #3 holding.
- Birmingham Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- Birmingham Capital Management's Eli Lilly position peaked at $12.8M in Q4 2025.
- 4,597 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Birmingham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.